Results 201 to 210 of about 161,301 (258)

Retraction: Clinical impact of monocyte distribution width and neutrophil-to-lymphocyte ratio for distinguishing COVID-19 and influenza from other upper respiratory tract infections: A pilot study. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Evaluating the effects of two parental self-management eHealth applications on antibiotic use, number of primary care visits and gut microbiota of febrile Dutch children with acute, uncomplicated upper respiratory tract infections: a study protocol for a randomised controlled trial. [PDF]

BMJ Open
Belt-van Zoen E, van Steenbergen N, Veldman L, Nieuwdorp M, Baars EW.   +4 more
europepmc   +1 more source

It takes a village: decreasing inappropriate antibiotic prescribing for upper respiratory tract infections. [PDF]

Antimicrob Steward Healthc Epidemiol
Shubeilat JL, Ilges D, Ton AN, Seville MTA.   +3 more
europepmc   +1 more source

[Upper respiratory tract infection].

Atencion primaria, 1991
openaire   +1 more source

Upper Respiratory Tract Infection

, 2009
openaire   +1 more source

Antimicrobial prescribing guidelines for feedlot cattle

Australian Veterinary Journal, EarlyView.
P Cusack, T Batterham, SW Page, GF Browning, JM Norris   +4 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Upper Respiratory Tract Infections

Pediatrics In Review, 2015
The upper respiratory system includes the nose, nasal cavity, pharynx, and larynx with subglottic area of trachea. In the normal circumstances, air enters the respiratory system through nostrils where it is filtered, humidified and warmed inside the nasal cavity.
Tekavec Trkanjec, Jasna, Peroš-Golubičić, Tatjana   +1 more
openaire   +3 more sources

Upper respiratory tract infections

Current Opinion in Pulmonary Medicine, 1999
In reviewing recent advances in upper respiratory tract infections, we focus on five key topics. First, the use of ribavirin in the treatment of respiratory syncytial virus infection has been limited to the immunosuppressed. Prophylaxis in high-risk patients with specific immunoglobulin is effective and a new monoclonal antibody shows promise.
D A, Moore, M, Sharland, J S, Friedland
openaire   +2 more sources